GH Research PLC (GHRS)

GH Research PLC is a clinical-stage biopharmaceutical company at the forefront of developing psilocybin-based therapies for psychiatric and neurodegenerative disorders. The company boasts a robust pipeline aimed at addressing critical unmet needs in mental health care, driven by a highly experienced team committed to innovation in this rapidly evolving field. By pioneering groundbreaking therapeutic approaches, GH Research is well-positioned to redefine treatment paradigms and enhance patient outcomes, establishing itself as a potential leader in the mental health therapeutics market.